期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
P-糖蛋白诱导作用的研究进展 被引量:6
1
作者 许悦 陈根富 +4 位作者 熊涛 彭英 阮婷婷 王广基 孙建国 《中国药科大学学报》 CAS CSCD 北大核心 2018年第1期26-33,共8页
P-糖蛋白(P-gp)是ATP结合盒转运体家族中重要的外排转运体。诱导作用可上调细胞外排转运体的表达并增强其功能,从而减少外源性有害异物造成的伤害,对维持细胞内环境稳态有重要作用。本文结合课题组的研究,综述了近年来P-gp的诱导模型、... P-糖蛋白(P-gp)是ATP结合盒转运体家族中重要的外排转运体。诱导作用可上调细胞外排转运体的表达并增强其功能,从而减少外源性有害异物造成的伤害,对维持细胞内环境稳态有重要作用。本文结合课题组的研究,综述了近年来P-gp的诱导模型、实验方法及其在新药研究中的应用。重点总结了多种P-gp的体外细胞诱导模型和体内动物诱导模型,检测P-gp基因、蛋白表达水平和外排转运功能的实验方法,以及P-gp与代谢酶、其他转运体的共同调节作用。同时介绍了以P-gp诱导进行临床解毒治疗的策略以及计算机辅助设计的P-gp诱导药效基团模型。本综述为临床前药物设计、新合成化合物诱导活性的筛选和潜在临床药物相互作用的预测提供一定的指导。 展开更多
关键词 P-糖蛋白 诱导 细胞模型 解毒作用
下载PDF
血必净注射液联合抗生素治疗脓毒症:两类药物间高水平药代和谐 被引量:7
2
作者 李坚 Olajide EOlaleye +11 位作者 余玄 贾伟伟 杨军令 吕闯 刘松桥 于晶晶 段小娜 王亚亚 董凯 贺容容 程晨 李川 《中国临床药理学与治疗学》 CAS CSCD 2020年第4期361-363,共3页
联合用药既需要药物间药效协同互补,也需要药物间能够“药代和谐”(pharmacokinetic compatibility,PKC;不发生会影响药物有效性或安全性的药代性质药物相互作用)。当今世界天然产物制品与化药一同使用既大量存在,又充满争议。一方面,... 联合用药既需要药物间药效协同互补,也需要药物间能够“药代和谐”(pharmacokinetic compatibility,PKC;不发生会影响药物有效性或安全性的药代性质药物相互作用)。当今世界天然产物制品与化药一同使用既大量存在,又充满争议。一方面,服用葡萄柚汁、圣约翰草制剂等能严重干扰同时进行的化药治疗,这使人们对天然产物制品与化药合用充满戒心;另一方面,越来越多严格的临床和基础研究证明,中药联合化药能更好地应对多因素疾病。脓毒症是一种由感染引起机体反应失调所导致危及生命的器官功能障碍,死亡率高、预后不良。 展开更多
关键词 抗生素治疗 天然产物 联合用药 注射液
下载PDF
低清除率药物的代谢稳定性预测模型研究进展 被引量:1
3
作者 阮婷婷 鞠武建 +3 位作者 熊海伟 姜利芳 许悦 王广基 《中国药科大学学报》 CAS CSCD 北大核心 2019年第2期152-160,共9页
药物代谢的稳定性测试是新药发现阶段的关键环节,实现药物的低清除率通常是药物代谢稳定性设计中的重要目标。如何准确评估低清除率药物的代谢稳定性参数,并用体外代谢数据预测人体药动学已经成为新药研发阶段的挑战。传统的肝微粒体模... 药物代谢的稳定性测试是新药发现阶段的关键环节,实现药物的低清除率通常是药物代谢稳定性设计中的重要目标。如何准确评估低清除率药物的代谢稳定性参数,并用体外代谢数据预测人体药动学已经成为新药研发阶段的挑战。传统的肝微粒体模型和悬浮肝细胞模型的孵育时间短,低清除率药物无法产生足够的代谢转化,因此进一步模拟体内环境和延长肝细胞培养时间的新型模型逐渐发展起来。本文重点介绍了新型的低清除率药物代谢稳定性预测模型的原理和优缺点等,包括肝细胞传递式培养模型、单层贴壁肝细胞培养模型、共培养模型和微灌流模型等,同时对模型的发展趋势进行展望,以期为早期先导化合物的代谢稳定性检测提供借鉴和优化。 展开更多
关键词 代谢稳定性 低清除率 传递式培养 共培养 微灌流 原药消除
下载PDF
利用液相色谱电解质效应结合脉冲梯度色谱技术提高药代筛选中生物样品液-质联用分析的速率 被引量:1
4
作者 李川 牛巍 +1 位作者 孙艳 王立 《中国临床药理学与治疗学》 CAS CSCD 2007年第10期1181-1181,共1页
Drug discovery calls for faster method development and high-throughput analysis in supporting drug metabolism and pharmacokinetic (PK) studies, whereas the rapid, sensitive, and accurate analysis of biological samples... Drug discovery calls for faster method development and high-throughput analysis in supporting drug metabolism and pharmacokinetic (PK) studies, whereas the rapid, sensitive, and accurate analysis of biological samples remains a significant challenge. For analysis of complex biomatrices (e.g. plasma), liquid chromatography (LC) interfaced to mass spectrometry (MS) or tandem mass spectrometry (MS/MS) has been hampered by adverse matrix effects. For rapid assay development, it would be beneficial to improve the time-consuming method comparison and optimization steps by using generic procedures that work for a variety of compounds. However, injudiciously combining the generic procedures including protein precipitation for sample clean-up and electrospray ionization (ESI) for detection, as well as using conventional short-time isocratic or gradient LC, yield fast assay development, but often at the cost of decreased assay accuracy and increased risk of assay failure. We previously reported that the use of a mobile phase containing an extremely low concentration of ammonium formate (HCOONH4) or formic acid (HCOOH) increased analyte ESI response and controlled against matrix effects. We designated these favorable effects ‘LC-electrolyte effects’. These favorable effects can be achieved in either the positive or the negative ion ESI mode, but not for atmospheric-pressure chemical ionization (APCI). The magnitude of the LC-electrolyte effect on the analyte response depends on both the concentration of the electrolyte modifier added into the mobile phase and its identity, which is also analyte-dependent. In addition, LC is often optimized with more emphasis on improving the analytical sensitivity by concentrating the analyte on the LC column leading to a narrow and symmetric band and achieving sufficient separation between analytes and polar matrix components to avoid adverse ion suppression or enhancement of MS-MS detection. For these reasons, we proposed the so-called ‘pulse gradient system’ for conventional HPLC-based MS-MS analyses of complex biological samples, which is generic and makes method development straightforward. In order to support rapid PK studies for drug discovery, we applied the LC-electrolyte effects and the pulse gradient chromatography to the development of generic procedures that can be used to quickly generate reliable PK data for compound candidates. We herein demonstrate our approach using four model tested compounds (Compd-A,-B,-C, and-D). The analytical methods involve generic protein precipitation for sample clean-up, followed by application of fast LC gradients and the subsequent use of electrospray ionization tandem mass spectrometry (ESI-MS/MS) for individual measurement of the tested compounds in 20 μL plasma samples. Good linearity over the concentration range of 1.6 or 8-25 000 ng/mL (r2>0.99), precision (RSD, 0.45%-13.10%), and accuracy (91%-112%) were achieved through the use of a low dose of formic acid (0.4 mmol/L or 0.015‰) in the methanol/water-based LC mobile phase. The analytical method was quite sensitive, providing a lower limit of quantification of 1.6 pg on-column except for Compd-C (8 pg), and showed negligible ion suppression caused by matrix components. Finally, the assay suitability was demonstrated in simulated discovery PK studies of the tested compounds with i.v./p.o. dosing to rats. This new assay approach has been adopted with good results in our laboratory for many recent discovery PK studies. 展开更多
关键词 液相色谱电解质效应 脉冲梯度色谱技术 药代筛选 生物样品 液-质联用 速率
下载PDF
静脉注射给药的甘草酸易在由肝转运体OATP1B1/OATP1B3介导的药物相互作用中成为被影响药物 被引量:2
5
作者 董佳佳 Olajide EOlaleye +8 位作者 姜蓉嵘 李静 吕闯 杜飞飞 徐方 杨军令 王凤清 贾伟伟 李川 《中国临床药理学与治疗学》 CAS CSCD 2020年第4期364-365,共2页
随意使用天然产品可能严重干扰患者正在接受的化药治疗,此已引起国际广泛关注。中西医结合治疗疾病在中国很普遍,研究中药与化药合用时发生药代性质药物相互作用风险,对于保证临床用药的有效性和安全性十分重要。不同于美英等西方国家,... 随意使用天然产品可能严重干扰患者正在接受的化药治疗,此已引起国际广泛关注。中西医结合治疗疾病在中国很普遍,研究中药与化药合用时发生药代性质药物相互作用风险,对于保证临床用药的有效性和安全性十分重要。不同于美英等西方国家,中国将中药作为药物来监管和使用,因此研究中药与化药合用的风险既涉及“中药影响化药”,也涉及“化药影响中药”。国际上围绕化药影响天然产物制品的研究还很少,这是因为与健康相关的天然产物制品在西方国家通常不具备药物身份,缺乏相应的药代动力学研究和技术。研究“化药影响中药”的风险首先应明确成分体内暴露改变能够影响中药的有效性或安全性,其重点是要搞清楚与化药合用能否通过某种机制改变这些中药成分的体内暴露。 展开更多
关键词 AUC 静脉注射给药 OATP1B1/OATP1B3 甘草酸
下载PDF
Liquid chromatography/tandem mass spectrometry method for quantitative estimation of solutol HS15 and its applications 被引量:1
6
作者 V.Vijaya Bhaskar Anil Middha +1 位作者 Pratima Srivastava Sriram Rajagopal 《Journal of Pharmaceutical Analysis》 SCIE CAS 2015年第2期120-129,共10页
A rapid, sensitive and selective pseudo MRM(p MRM)-based method for the determination of solutol HS15(SHS15) in rat plasma was developed using liquid chromatography/tandem mass spectrometry(LC–MS/MS). The most ... A rapid, sensitive and selective pseudo MRM(p MRM)-based method for the determination of solutol HS15(SHS15) in rat plasma was developed using liquid chromatography/tandem mass spectrometry(LC–MS/MS). The most abundant ions corresponding to SHS15 free polyethyleneglycol(PEG)oligomers at m/z 481, 525, 569, 613, 657, 701, 745, 789, 833, 877, 921 and 965 were selected for p MRM in electrospray mode of ionization. Purity of the lipophilic and hydrophilic components of SHS15 was estimated using evaporative light scattering detector(ELSD). Plasma concentrations of SHS15 were measured after oral administration at 2.50 g/kg dose and intravenous administration at 1.00 g/kg dose in male Sprague Dawley rats. SHS15 has poor oral bioavailability of 13.74% in rats. Differences in pharmacokinetics of oligomers were studied. A novel proposal was conveyed to the scientific community,where formulation excipient could be analyzed as a qualifier in the analysis of new chemical entities(NCEs) to address the spiky plasma concentration profiles. 展开更多
关键词 SHS15 LC–MS/MS Spiky profiles Validation
下载PDF
New Convenient Synthesis of 8-C-Methylated Homoisoflavones and Analysis of Their Structure by NMR and Tandem Mass Spectrometry
7
作者 Santosh Kumar Yadav 《International Journal of Organic Chemistry》 CAS 2021年第1期46-54,共9页
Homoisoflavonoids are in the subclass of the larger family of flavonoids having one more alkyl carbon than flavonoids. Among them, 8-C-Methylated homoisoflavones have not been extensively studied for synthesis and bio... Homoisoflavonoids are in the subclass of the larger family of flavonoids having one more alkyl carbon than flavonoids. Among them, 8-C-Methylated homoisoflavones have not been extensively studied for synthesis and biological evaluation. Author’s current objective is to synthesize 8-C-Methylated homoisoflavones by the reaction of 3-C-methylated dihydrochalcones with N,N’-dimethyl (chloromethylene) ammonium chloride generated<em> in situ</em> from DMF and PCl<sub>5</sub> for one carbon extension at about room temperature. The 3-C-methylated dihydrochalcones were synthesized by the reduction of 3-C-methylated chalcones, which were prepared from 3-C-methylated acetophenones and aromatic aldehydes in the presence of base. All the synthesized novel homoisoflavones’s structures were characterized by NMR and Tandem Mass Spectrometry. 展开更多
关键词 8-C-Methylated Homoisoflavones 3-C-Methylated Dihydrochalcones 3-C-Methylated Chalcones 3-C-Methylated Acetophenones DIMETHYLFORMAMIDE BF3·Et2O PCl5
下载PDF
异源物代谢的表观遗传学变异影响抗癫痫药3,4-DCPB药物代谢动力学表型个体差异
8
作者 逯颖媛 张梅 +12 位作者 尹胜菊 董晓娜 张志远 程海旭 屠鹏飞 窦桂芳 车永胜 徐争辉 徐枫 王宪 吕闯 楼雅卿 章国良 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2023年第1期1-16,共16页
抗癫痫药物治疗是控制癫痫的主要方法,但由于个体间对药物处置的差异性,患者对目前治疗的反应性并不一致。本研究通过在健康志愿者中进行的临床Ⅰ期剂量递增试验,考察了遗传和表观遗传变异是否影响抗癫痫药物氯桂丁胺(3,4-DCPB)的药代... 抗癫痫药物治疗是控制癫痫的主要方法,但由于个体间对药物处置的差异性,患者对目前治疗的反应性并不一致。本研究通过在健康志愿者中进行的临床Ⅰ期剂量递增试验,考察了遗传和表观遗传变异是否影响抗癫痫药物氯桂丁胺(3,4-DCPB)的药代动力学表型。采用液相色谱-串联质谱(LC-MS/MS)法测定血浆中3,4-DCPB母药及其主要代谢物M1的浓度。通过基因分型和DNA甲基化水平分析细胞色素P4502D6(CYP2D6)、CYP2C9、CYP1A2、CYP2C19、CYP3A5、转运体ABCB1(C1236T)、核受体AhR、CAR和PXR的单核苷酸多态性(SNPs)。与野生型CYP2D6*1/*1纯合子(广泛代谢型,EMs)相比,变异等位基因CYP2D6*10携带者(中间代谢型,IMs)中,代谢产物M1与3,4-DCPB母药的药时曲线下面积(AUC0–t)的比值更低,血浆半衰期(t1/2)更久,DNA甲基化水平更高。这些数据表明胞嘧啶的丢失(CYP2D6*10,C>T)所诱导的表观基因突变可能解释3,4-DCPB基因型、表观基因型和药代动力学表型在个体差异之间的关系,为癫痫的个性化治疗提供新的思路。 展开更多
关键词 药物代谢动力学 抗癫痫药氯桂丁胺 个体差异 DNA甲基化 CYP2D6*10携带者 表突变 临床Ⅰ期剂量递增试验
原文传递
PBPK modeling and simulation in drug research and development 被引量:23
9
作者 Xiaomei Zhuang Chuang Lu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2016年第5期430-440,共11页
Physiologically based pharmacokinetic(PBPK) modeling and simulation can be used to predict the pharmacokinetic behavior of drugs in humans using preclinical data.It can also explore the effects of various physiologic ... Physiologically based pharmacokinetic(PBPK) modeling and simulation can be used to predict the pharmacokinetic behavior of drugs in humans using preclinical data.It can also explore the effects of various physiologic parameters such as age,ethnicity,or disease status on human pharmacokinetics,as well as guide dose and dose regiment selection and aid drug–drug interaction risk assessment.PBPK modeling has developed rapidly in the last decade within both the field of academia and the pharmaceutical industry,and has become an integral tool in drug discovery and development.In this mini-review,the concept and methodology of PBPK modeling are briefly introduced.Several case studies were discussed on how PBPK modeling and simulation can be utilized through various stages of drug discovery and development.These case studies are from our own work and the literature for better understanding of the absorption,distribution,metabolism and excretion(ADME) of a drug candidate,and the applications to increase efficiency,reduce the need for animal studies,and perhaps to replace clinical trials.The regulatory acceptance and industrial practices around PBPK modeling and simulation is also discussed. 展开更多
关键词 PBPK PK prediction ABSORPTION METABOLISM Drug–drug interaction SPECIAL POPULATION
原文传递
Review of Rhubarbs: Chemistry and Pharmacology 被引量:26
10
作者 ZHENG Qing-xia WU Hai-feng +4 位作者 GUO Jian NAN Hai-jiang CHEN Shi-lin YANG Jun-shan XU Xu-dong 《Chinese Herbal Medicines》 CAS 2013年第1期9-32,共24页
Rhubarb is a perennial herb belonging to the genus Rheum L. (Polygonaceae). Rhei Radix et Rhizoma (rhubarb roots and rhizomes) is one of the most popular Chinese materia medica and has been widely used for strong laxa... Rhubarb is a perennial herb belonging to the genus Rheum L. (Polygonaceae). Rhei Radix et Rhizoma (rhubarb roots and rhizomes) is one of the most popular Chinese materia medica and has been widely used for strong laxative function. About 200 compounds with six different types of skeletons (anthraquinone, anthrone, stilbene, flavonoids, acylglucoside, and pyrone) have so far been isolated from eighteen species of the genus Rheum L. These constituents showed extensive pharmacological activities including cathartic, diuretic, anticancer, hepatoprotective, anti-inflammatory, and analgesic effects, as well as toxicological effects. Chemical fingerprint, LC-MS, and other analytical techniques have been used for the quality control of rhubarb. This comprehensive review summarizes the researches into the isolation, pharmacological activities, and phytochemical analysis reported since investigations began in the late 1940s. In addition, pharmacokinetic studies and clinical application of rhubarb are also discussed in present paper. 展开更多
关键词 pharmacokinetic studies pharmacological activities quality control Rheum L. RHUBARB
原文传递
High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care 被引量:10
11
作者 Jian Li Olajide E.Olaleye +11 位作者 Xuan Yu Weiwei Jia Junling Yang Chuang Lu Songqiao Liu Jingjing Yu Xiaona Duan Yaya Wanga Kai Dong Rongrong He Chen Cheng Chuan Li 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2019年第5期1035-1049,共15页
Managing the dysregulated host response to infection remains a major challenge in sepsis care. Chinese treatment guideline recommends adding Xue Bi Jing, a five-herb medicine, to antibioticbased sepsis care. Although ... Managing the dysregulated host response to infection remains a major challenge in sepsis care. Chinese treatment guideline recommends adding Xue Bi Jing, a five-herb medicine, to antibioticbased sepsis care. Although adding Xue Bi Jing further reduced 28-day mortality via modulating the host response, pharmacokinetic herbedrug interaction is a widely recognized issue that needs to be studied.Building on our earlier systematic chemical and human pharmacokinetic investigations of Xue Bi Jing, we evaluated the degree of pharmacokinetic compatibility for Xue Bi Jing/antibiotic combination based on mechanistic evidence of interaction risk. Considering both Xue Bi Jing-antibiotic and antibiotic-Xue Bi Jing interaction potential, we integrated informatics-based approach with experimental approach and developed a compound pair-based method for data processing. To reflect clinical reality, we selected for study Xue Bi Jing compounds bioavailable for drug interactions and 45 antibiotics commonly used in sepsis care in China. Based on the data of interacting with drug metabolizing enzymes and transporters, no Xue Bi Jing compound could pair, as perpetrator, with the antibiotics. Although some antibiotics could,due to their inhibition of uridine 50-diphosphoglucuronosyltransferase 2 B15, organic anion transporters1/2 and/or organic anion-transporting polypeptide 1 B3, pair with senkyunolide I, tanshinol and salvianolic acid B, the potential interactions(resulting in increased exposure) are likely desirable due to these Xue Bi Jing compounds’ low baseline exposure levels. Inhibition of aldehyde dehydrogenase by 7 antibiotics probably results in undesirable reduction of exposure to protocatechuic acid from Xue Bi Jing.Collectively, Xue Bi Jing/antibiotic combination exhibited a high degree of pharmacokinetic compatibility at clinically relevant doses. The methodology developed can be applied to investigate other drug combinations. 展开更多
关键词 XUEBIJING Antibiotic Combination DRUG therapy SEPSIS PHARMACOKINETIC compatibility Herb-drug interaction
原文传递
Identification of human cytochrome P450 and UGT enzymes involved in the metabolism of ferulic acid, a major bioactive component in traditional Chinese medicines
12
作者 ZHUANG Xiao-Mei CHEN Lin +4 位作者 TAN Yan YANG Hai-Ying LU Chuang GAO Yue LI Hua 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2017年第9期695-702,共8页
Ferulic acid(FA) is an active component of herbal medicines. One of the best documented activities of FA is its antioxidant property. Moreover, FA exerts antiallergic, anti-inflammatory, and hepatoprotective effects. ... Ferulic acid(FA) is an active component of herbal medicines. One of the best documented activities of FA is its antioxidant property. Moreover, FA exerts antiallergic, anti-inflammatory, and hepatoprotective effects. However, the metabolic pathways of FA in humans remain unclear. To identify whether human CYP or UGT enzymes are involved in the metabolism of FA, reaction phenotyping of FA was conducted using major CYP-selective chemical inhibitors together with individual CYP and UGT Supersomes. The CYPand/or UGT-mediated metabolism kinetics were examined simultaneously or individually. Relative activity factor and total normalized rate approaches were used to assess the relative contributions of each major human CYPs towards the FA metabolism. Incubations of FA with human liver microsomes(HLM) displayed NADPH-and UDPGA-dependent metabolism with multiple CYP and UGT isoforms involved. CYPs and UGTs contributed equally to the metabolism of FA in HLM. Although CYP1 A2 and CYP3 A4 appeared to be the major contributors in the CYP-mediated clearance, their contributions to the overall clearance are still minor(< 25%). As a constitute of many food and herbs, FA poses low drug-drug interaction risk when co-administrated with other herbs or conventional medicines because multiple phase I and phase II enzymes are involved in its metabolism. 展开更多
关键词 Ferulic 植物药相互作用 反应 phenotyping 人的肝微体
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部